SEER INC. CL.A O.N.

Squarepoint Ops LLC reduced its position in shares of Seer, Inc. (NASDAQ:SEER – Free Report) by 46.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,156 shares of the company’s stock after selling 25,168 shares during the quarter. Squarepoint Ops LLC’s holdings in Seer were worth $67,000 as of its most recent filing with the Securities & Exchange Commission. Several other institutional investors also recently bought and sold shares of the company. Two Sigma Advisers LP increased its holdings in Seer by 24.2% during the 4th quarter. Two Sigma Advisers LP now owns 681,900 shares of the company’s stock worth $1,575,000 after purchasing an additional 132,800 shares during the period. OMERS ADMINISTRATION Corp bought a new position in Seer in the fourth quarter worth approximately $114,000. Millennium Management LLC raised its stake in Seer by 9.1% in the fourth quarter. Millennium Management LLC now owns 615,812 shares of the company’s stock worth $1,423,000 after buying an additional 51,150 shares in the last quarter. D. E. Shaw & Co. Inc. raised its stake in Seer by 16.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 719,901 shares of the company’s stock worth $1,663,000 after buying an additional 103,630 shares in the last quarter. Finally, Bridgeway Capital Management LLC raised its stake in Seer by 17.6% in the fourth quarter. Bridgeway Capital Management LLC now owns 727,743 shares of the company’s stock worth $1,681,000 after buying an additional 109,000 shares in the last quarter. 75.20% of the stock is currently owned by hedge funds and other institutional investors. Seer Stock Up 1.4% Shares of NASDAQ:SEER opened at $2.23 on Wednesday. The company has a market capitalization of $131.28 million, a price-to-earnings ratio of -1.72 and a beta of 1.54. Seer, Inc. has a 52 week low of $1.56 and a 52 week high of $2.63. The firm has a 50 day moving average of $2.01 and a 200 day moving average of $2.15. Seer (NASDAQ:SEER – Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.34) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.03. The company had revenue of $4.21 million during the quarter, compared to the consensus estimate of $3.25 million. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. On average, sell-side analysts expect that Seer, Inc. will post -1.42 EPS for the current year. Seer Company Profile (Free Report) Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.» Mehr auf defenseworld.net

Does Seer, Inc. (SEER) have what it takes to be a top stock pick for momentum investors? Let's find out.» Mehr auf zacks.com

First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics» Mehr auf globenewswire.com